|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
2/13/2008 8:52:13 AM
WAKEFIELD, Mass. - Implant Sciences Corporation (AMEX: IMX), a leading manufacturer of advanced security products, today announced the execution of a binding letter of intent to acquire San Diego, California-based Ion Metrics, Inc. (“Ion Metrics”). In connection with this transaction, the Company plans to acquire all the assets of Ion Metrics, including its mass spectrometer (“MS”) technology, differential mobility spectrometer (“DMS”) technology, ion mobility spectrometry (“IMS”) technology, miniature, light weight vacuum pump technology, patents, manufacturing fixtures, and other related technological capabilities. The Company will also be assuming certain specified liabilities. The Company plans to issue 2 million shares of its common stock as consideration for the transaction. The common stock to be issued will be restricted pursuant to the provisions of Securities and Exchange Commission Rule 144. The acquisition is subject to the execution of a definitive purchase agreement, which is expected to occur no later than March 31, 2008, and the satisfaction of other conditions which are customary in these types of transactions.
|
|
|
|
|
|
|
|
|
|
|